Details of the Drug

General Information of Drug (ID: DM05P9R)

• Drug Name: Curmucin

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]

• Cross-matching ID: TTD ID: D01LFH

References

• [1] ClinicalTrials.gov (NCT02138955) A Phase IB Dose Escalation Study of Lipocurc in Patients With Cancer. U.S. National Institutes of Health.